Hadassah

Hadassah Launches New Center for Treating Pediatric Vascular Defects

Tuesday, Apr 30 2013

The Hadassah Medical Organization has opened a multidisciplinary facility to treat pediatric vascular defects—a first for Israel. Ten percent of infants are born with vascular defects in various areas of the body. Vascular defects can develop while the child is still in utero and resulting symptoms can appear either at birth or later on during a child's adolescent years.

For most of these children, the defect will disappear within seven years; however, some may be left with scarring or aesthetic damage. Although only one percent of children born with vascular deformities need treatment to correct the defects in main arteries and airways, in many cases, the condition is not diagnosed correctly, which can prove life-threatening.

Until now, infants and children were sent abroad for corrective surgery. With the opening of the new center at Hadassah, these children can receive the same quality of treatment in Israel, as specialists from plastic surgery, dermatology, laryngology, diagnostic radiology, angiography, and invasive radiology combine their talents to build a comprehensive treatment plan.

"Today, we have access to minimally invasive measures for effective treatment," relates Dr. Adam Farkas of Hadassah's Vascular and Interventional Radiology Unit. "Early detection is the key, because it allows children to grow and develop well, both physically and socially, and to avoid unnecessary pain and suffering."

One method of treatment closes off the problematic blood vessels via insertion of a catheter through the groin. The area is cauterized until the vein or artery has shrunk to the point of blocking blood flow to the area, thus eventually causing it to disappear. The other treatment method is sclerotherapy, which also shrinks the problematic blood vessel, but with an injection of a special solution.

Dr. Farkas, age 32, who was born and raised in New York, recently immigrated to Israel with his wife and four children. He has a special interest in venous diseases and vascular malformations, for which he underwent specialized training at Boston (MA) Children's Hospital, an affiliate of Harvard Medical School. He has since brought to Hadassah some of the cutting-edge therapies he learned at Harvard.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Feb 14 2018

Student with MS Running the Jerusalem Marathon to Support Hadassah’s MS Program

Thanks to his physicians at the Hadassah Medical Center, Dov Guggenheim, who was diagnosed with Multiple Sclerosis (MS) in 2015, has gone from “depressed to optimistic, paralyzed to athletic, and, most important, hopeless to hopeful.”

READ MORE ›
alt_text

Wednesday, Feb 7 2018

Texas Tropical Disease Expert Meets with Hadassah Infectious Disease Specialists

Dr. Peter Jay Hotez, renowned professor in the Departments of Pediatrics and Molecular Virology and Microbiology at Houston (Texas) Baylor College of Medicine and Dean of its National School of Tropical Medicine, met with two Hadassah Medical Organization infectious disease specialists to discuss regional cooperation in fighting tropical diseases, such as the now-infamous Zika virus and leishmaniosis, which is contracted from sand flies.

READ MORE ›
alt_text

Wednesday, Feb 7 2018

Large Hadassah Study Identifies Predictor of Greater Risk of End-Stage Renal Disease

The findings of a nationwide study of over a million and a half Israeli adolescents, conducted by researchers at the Hadassah-Hebrew University Braun School of Public Health and Community Medicine, suggest that kidney disease in childhood is associated with a significantly increased risk of end-stage renal disease (ESRD) in adulthood, even if kidney function seems normal in adolescence.

READ MORE ›
alt_text

Wednesday, Feb 7 2018

Israeli Start-up’s Algorithm Predicts Which Diabetic Patients Will Suffer Kidney Dysfunction Within One Year

The Israeli start-up Medial EarlySign has created a machine-learning-based model that has proven to identify diabetic patients who are at the highest risk for experiencing renal dysfunction within one year.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More